Published

Psychedelic drugs and the law: What’s next?

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Knowable Magazine
Date: 2024-03-14
Source: OpenAlex
DOI: 10.1146/knowable-031424-2
PubMed: Unavailable

Authors

Ben Seal

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety PTSD Addiction End-of-Life Distress Chronic Pain Mechanism of Action Receptor Pharmacology Spirituality Clinical Trial Systematic Review Review Article Cancer Patients Safety Systematic Review

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelic drugs and the law: What’s next?2024-03-14

Related papers

Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysisJournal of Psychedelic Studies · 2026-05-29 A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With FibromyalgiaClinicalTrials.gov · 2025-04-16 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulationsPsychiatry and Clinical Neurosciences · 2026-06-01 Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?Pain management · 2018-05-01 Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use DisorderClinicalTrials.gov · 2026-08-06 Psychedelic Experiences and Finitude in Serious Illness: A Qualitative SynthesisJournal of Pain and Symptom Management · 2026-03-26 Are psychedelics the answer to chronic pain: A review of current literature.Pain practice: the official journal of World Institute of Pain · 2023-04-01